Editorial on the Research Topic Disease biomarker analysis based on optical biosensingDisease biomarker analysis has become a crucial tool for diagnosing and evaluating disease prognosis, especially with the increasing understanding of diseases at the molecular level. Abnormalities in various biomarkers can indicate diseased states, and can be used to rapidly and specifically detect and quantify diseases using optical biosensing techniques (Gao et al., 2023). Optical biosensing techniques have several advantages over traditional methods including higher sensitivity, specificity, and faster analysis times (Plikusiene and Ramanaviciene, 2023). It also allows for non-invasive sample collection. With advancements in optical biosensing technology, many medical conditions including cancers, infectious diseases, and autoimmune disorders can be accurately diagnosed and efficiently treated (Singh et al., 2023;Tang et al., 2023). The combination of optical biosensing with emerging technologies such as material science, optics, and electronics has further accelerated its development in biomarker analysis (Qureshi et al., 2022). Interdisciplinary collaboration between experts in fields such as physics, chemistry, bioengineering, and medicine has helped pave the way for novel optical biosensing technologies as well as improving existing ones. Continued interdisciplinary collaboration is essential in advancing the field of disease biomarker analysis based on optical biosensing. This exciting area of research holds great potential for the future of personalized and precision medicine, and will likely lead to more effective disease diagnoses and treatments (Duo et al., 2023).In order to highlight the most up-to-date research in this field, a Research Topic titled "Disease Biomarker Analysis Based on Optical Biosensing" was launched in Analytical Chemistry in Frontiers. The Research Topic consists of a total of 5 articles, which include 3 original research articles and 2 review articles. Through these publications, novel insights and significant discoveries are presented in the area of optical biosensing, contributing greatly to the advancement of this rapidly evolving field.Bio-nanomicelles based on biomaterials such as nucleic acids, peptides, glycans, and lipids have rapidly developed in the field of bioanalysis (Yang et al., 2020). However, few bionanomicelles integrate DNA with peptides, which can provide unique advantages for biomedical applications. In light of this, Feng et al. designed a peptide-DNA hybrid bio-